Concepedia

Publication | Closed Access

6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

DOI

56

Citations

0

References

2015

Year

J. Strosberg, Edward M. Wolin, Beth Chasen, Michael Kulke, David Bushnell, M. Caplin, R. P. Baum, Erik Mittra, Timothy J. Hobday, Andrew Hendifar,
European Journal of Cancer

No additional data available for this publication yet. Check back later!